High expression of herpes virus entry mediator is associated with poor prognosis in clear cell renal cell carcinoma

被引:1
|
作者
Tang, Ming [1 ]
Cao, Xu [1 ]
Li, You [1 ]
Li, Gui-Qing [2 ]
He, Qian-Hui [3 ]
Li, Shu-Jing [3 ]
Chen, Jian [2 ]
Xu, Gui-Lian [2 ]
Zhang, Ke-Qin [1 ]
机构
[1] Third Mil Med Univ, Army Med Univ, Southwest Hosp, Dept Nephrol, 30 Gaotanyan Main St, Chongqing 400038, Peoples R China
[2] Third Mil Med Univ, Army Med Univ, Dept Immunol, Chongqing 400038, Peoples R China
[3] Chongqing Med Univ, Affiliated Hosp 2, Dept Nephrol, Chongqing 400016, Peoples R China
来源
AMERICAN JOURNAL OF CANCER RESEARCH | 2019年 / 9卷 / 05期
基金
中国国家自然科学基金;
关键词
Clear cell renal cell carcinoma; herpes virus entry mediator; disease-free survival; overall survival; prognostic biomarker; CANCER; HVEM; BTLA; LYMPHOCYTE; ACTIVATION; PATHWAY; TARGETS; CD160;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Herpes virus entry mediator (HVEM), also called tumor necrosis factor receptor superfamily 14 (TNFRSF14), is highly expressed in various tumor tissues and plays critical roles in tumor biology. However, the role of HVEM in clear cell renal cell carcinoma (ccRCC) is unknown. This study evaluated the clinical importance of HVEM in patients with ccRCC. HVEM expression was assessed in fresh and 140 archived paraffin-embedded ccRCC tissue samples by quantitative RT-PCR, western blot, and immunohistochemical staining. HVEM expression was higher in ccRCC than in paired peritumor tissue. Kaplan-Meier analysis showed that high level of HVEM expression was associated with poor overall survival (OS) and disease-free survival (DFS) in patients with ccRCC (both P < 0.001). Multivariate analysis indicated that HVEM overexpression was independently prognostic of survival in ccRCC patients. Two novel nomogram systems were constructed by integrating HVEM expression and other clinical parameters to predict OS (c-index 0.75) and DFS (c-index 0.74) in these patients, with both having better predictive accuracy than traditional TNM (c-index 0.65 for OS and 0.639 for DFS) and Fuhrman (c-index 0.612 for OS and 0.641 for DFS) systems. In addition, HVEM silencing led to an observable reduction in tumor cells growth in vitro and in vivo. Taken together, these findings indicate that high HVEM expression is a novel and independent adverse predictor of clinical outcomes in patients with ccRCC and that HVEM may be a potential therapeutic target.
引用
收藏
页码:975 / +
页数:14
相关论文
共 50 条
  • [1] Hemoglobin β Expression Is Associated with Poor Prognosis in Clear Cell Renal Cell Carcinoma
    Kurota, Yuta
    Takeda, Yuji
    Ichiyanagi, Osamu
    Saitoh, Shinichi
    Ito, Hiromi
    Naito, Sei
    Asao, Hironobu
    Tsuchiya, Norihiko
    [J]. BIOMEDICINES, 2023, 11 (05)
  • [2] High CHD9 expression is associated with poor prognosis in clear cell renal cell carcinoma
    Guan, Bo
    Ran, Xian-Gui
    Du, Yong-Qiang
    Ren, Feng
    Tian, Ye
    Wang, Ying
    Chen, Ming-Min
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2018, 11 (07): : 3697 - 3702
  • [3] High expression of APRIL correlates with poor prognosis in clear cell renal cell carcinoma
    Lee, Cheol
    Park, Jeong-Whan
    Suh, Ja Hee
    Moon, Kyung Chul
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 2015, 211 (11) : 824 - 828
  • [4] High Hepcidin expression predicts poor prognosis in patients with clear cell renal cell carcinoma
    Tang, Yuting
    Ge, Shengdong
    Zheng, Xiao
    Zheng, Jiejiao
    [J]. DIAGNOSTIC PATHOLOGY, 2022, 17 (01)
  • [5] High Hepcidin expression predicts poor prognosis in patients with clear cell renal cell carcinoma
    Yuting Tang
    Shengdong Ge
    Xiao Zheng
    Jiejiao Zheng
    [J]. Diagnostic Pathology, 17
  • [6] High Expression of CD39 is Associated with Poor Prognosis and Immune Infiltrates in Clear Cell Renal Cell Carcinoma
    Wu, Jie
    Wang, Yu-Chen
    Xu, Wen-Hao
    Luo, Wen-Jie
    Wan, Fang-Ning
    Zhang, Hai-Liang
    Ye, Ding-Wei
    Qu, Yuan-Yuan
    Zhu, Yi-Ping
    [J]. ONCOTARGETS AND THERAPY, 2020, 13 : 10453 - 10464
  • [7] Loss of Caspase 7 Expression Is Associated With Poor Prognosis in Renal Cell Carcinoma Clear Cell Subtype
    Vilella-Arias, Santiago A.
    Rocha, Rafael Malagoli
    da Costa, Walter Henriques
    Zequi, Stenio de Cassio
    Guimaraes, Gustavo Cardoso
    Verjovski-Almeida, Sergio
    Soares, Fernando A.
    Reis, Eduardo M.
    [J]. UROLOGY, 2013, 82 (04) : 974.e1 - 974.e7
  • [8] Decreased expression of miR-495 is associated with poor prognosis in clear cell renal cell carcinoma
    Zheng Shubei
    Zheng Yu
    Jin Lingwei
    Zhou Zhihong
    Li Zhanyuan
    [J]. BIOMEDICAL RESEARCH-INDIA, 2017, 28 (13): : 5968 - 5971
  • [9] High Expression of DNTTIP1 Predicts Poor Prognosis in Clear Cell Renal Cell Carcinoma
    Wang, Xuegang
    Li, Weiquan
    Lou, Ning
    Han, Weiwei
    Hai, Bo
    Xiao, Wen
    Zhang, Xiaoping
    [J]. PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2023, 16 : 1 - 14
  • [10] High expression of FUT3 is linked to poor prognosis in clear cell renal cell carcinoma
    Meng, Li
    Xu, Le
    Yang, Yuanfeng
    Zhou, Lin
    Chang, Yuan
    Shi, Tianming
    Tan, Cheng
    An, Huimin
    Zhu, Yu
    Xu, Jiejie
    [J]. ONCOTARGET, 2017, 8 (37) : 61036 - 61047